GPX7 and central nervous system cancer: In addition, GPX7 knockdown and erastin cotreatment significantly inhibited the migratory and invasive abilities (Figures 5B, C) and increased apoptosis (Figure 5D) of glioma cells, while GPX7 knockdown alone did not exhibit obvious effects.